181 results
Page 3 of 10
8-K
6uzd1z0sn7d qfuy8l
7 May 21
Entry into a Material Definitive Agreement
7:09am
8-K
EX-99.2
jgt5wz j5
7 May 21
Entry into a Material Definitive Agreement
7:09am
8-K
EX-99.1
k34bj
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-99.2
drtuvn0isclb2 vkg
7 May 21
Business combination disclosure
7:08am
425
EX-99.1
vcd8us3ql0 inb
7 May 21
Business combination disclosure
7:08am
425
zhq2 a66p
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
igmaom3
9 Mar 21
Acasti Pharma Provides Update on Recent Financing Activities
12:00am
8-K
EX-99.1
u8cy1i
27 Jan 21
Acasti Pharma Provides Update on Recent Financing Activities
7:35am
8-K
EX-99.1
goteo3n nb1o
16 Nov 20
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
7:05am
8-K
EX-99.1
nhss9jkb
29 Sep 20
Acasti Announces Review Process of Strategic Alternatives
8:19am
8-K
EX-99.1
gdz37
17 Sep 20
Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
9:54pm
DEF 14A
9gm91u1lse dz0x1qzpl
9 Sep 20
Definitive proxy
4:00pm
8-K
EX-99.1
i4d591kj0t0hz4vztofu
31 Aug 20
Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia
4:05pm
10-Q
6imdzk3608ml6 o55w
13 Aug 20
Quarterly report
8:30am
8-K
EX-99.1
0tw z8jatxf9kw53n0
13 Aug 20
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
8:30am
PRE 14A
8q52xtpmqy9jz1eszoms
10 Aug 20
Preliminary proxy
12:00am
8-K
EX-99.1
9wb8v7hwc iewut7f
31 Jul 20
Regulation FD Disclosure
4:05pm